Market Recap Check: Tempest Therapeutics Inc (TPST)’s Negative Finish at 0.61, Up/Down -14.53

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

The price of Tempest Therapeutics Inc (NASDAQ: TPST) closed at $0.61 in the last session, down -14.53% from day before closing price of $0.72. In other words, the price has decreased by -$14.53 from its previous closing price. On the day, 1.4 million shares were traded. TPST stock price reached its highest trading level at $0.71 during the session, while it also had its lowest trading level at $0.5997.

Ratios:

We take a closer look at TPST’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.21 and its Current Ratio is at 2.21. In the meantime, Its Debt-to-Equity ratio is 0.80 whereas as Long-Term Debt/Eq ratio is at 0.43.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 14, 2024, initiated with a Sector Outperform rating and assigned the stock a target price of $13.

On February 08, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 12 ’24 when Versant Venture Capital VI, L. bought 387,999 shares for $1.10 per share.

Versant Venture Capital VI, L. sold 400,000 shares of TPST for $540,040 on Aug 08 ’24. The 10% Owner now owns 597,940 shares after completing the transaction at $1.35 per share. On Aug 12 ’24, another insider, Versant Venture Capital VI, L., who serves as the 10% Owner of the company, sold 387,999 shares for $1.10 each. As a result, the insider received 426,993 and left with 209,941 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TPST now has a Market Capitalization of 27931356 and an Enterprise Value of 13028346.

Stock Price History:

The Beta on a monthly basis for TPST is -1.73, which has changed by -0.8461153 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, TPST has reached a high of $5.31, while it has fallen to a 52-week low of $0.70. The 50-Day Moving Average of the stock is -27.36%, while the 200-Day Moving Average is calculated to be -48.19%.

Shares Statistics:

According to the various share statistics, TPST traded on average about 809.02K shares per day over the past 3-months and 664340 shares per day over the past 10 days. A total of 43.97M shares are outstanding, with a floating share count of 41.29M. Insiders hold about 9.21% of the company’s shares, while institutions hold 6.25% stake in the company. Shares short for TPST as of 1741910400 were 1752444 with a Short Ratio of 2.17, compared to 1739491200 on 2109508. Therefore, it implies a Short% of Shares Outstanding of 1752444 and a Short% of Float of 4.34.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular